Backup plan offered for myeloma patients when custom cell therapy fails quality check
NCT ID NCT04771078
Summary
This program provides access to a cell therapy called ide-cel for people with multiple myeloma when the specific batch made for them doesn't pass all the standard quality checks for commercial sale. It's for patients who are clinically stable and for whom making a new batch isn't feasible. The goal is to evaluate the safety and effectiveness of using these special batches.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.